Alpine Global Management’s VeriSign VRSN Stock Holding History

Alpine Global Management’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,613	Closed	-$503K	–	435
2019 Q4	$503K	Buy	+2,613	New	+$491K	0.11%	152
2015 Q3	–	Sell	-472	Closed	-$29K	–	795
2015 Q2	$29K	Buy	+472	New	+$30.4K	﹤0.01%	884

Other funds holding VRSN

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpine Global Management's VRSN Position: Q1 2020 in Review

Alpine Global Management sold out of VeriSign (VRSN) in Q1 2020, closing a stake of 2,613 shares — an estimated $503K sold.

Alpine Global Management first reported a position in VRSN in Q2 2015 and held it in 2 quarters. The position peaked at $503K in Q4 2019. 541 funds tracked by Wall St. Rank hold VRSN as of Q1 2020.

Alpine Global Management reported no remaining VeriSign position as of Q1 2020 after selling out during the quarter.
Alpine Global Management sold 2,613 VeriSign shares in Q1 2020, an estimated $503K.
Alpine Global Management first reported a position in VeriSign in Q2 2015 and held it in 2 quarters.
Alpine Global Management's VeriSign position peaked at $503K in Q4 2019.
541 funds tracked by Wall St. Rank held VeriSign as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.